Central Nervous System Drugs

Parkinson Disease Drugs Practice Questions

20 free Parkinson Disease Drugs practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Parkinson Disease Drugs questions

20 questions
  1. Q1. Which neurotransmitter deficiency is primarily responsible for the motor symptoms of Parkinson disease?
  2. Q2. Which drug is considered the most effective treatment for the motor symptoms of Parkinson disease?
  3. Q3. Why is levodopa commonly combined with carbidopa in Parkinson disease therapy?
  4. Q4. Which class of Parkinson disease drugs acts directly on striatal receptors without needing conversion into an active neurotransmitter?
  5. Q5. Which drug is a dopamine agonist used in Parkinson disease?
  6. Q6. Which enzyme inhibitor prevents dopamine breakdown in the brain and is used in Parkinson disease?
  7. Q7. Which drug is an MAO-B inhibitor used in Parkinson disease treatment?
  8. Q8. Which drug class prolongs the action of levodopa by blocking the enzyme that methylates it in the periphery?
  9. Q9. Which drug is a COMT inhibitor used with levodopa therapy?
  10. Q10. Which drug originally developed as an antiviral agent is used to treat Parkinson disease symptoms?
  11. Q11. Which symptom of Parkinson disease is most improved by levodopa therapy?
  12. Q12. Which adverse effect is commonly associated with long-term levodopa therapy?
  13. Q13. Which drug class helps reduce tremor in Parkinson disease by blocking muscarinic receptors?
  14. Q14. Which anticholinergic drug is used in Parkinson disease treatment?
  15. Q15. Which brain structure is primarily affected in Parkinson disease?
  16. Q16. Which drug class may delay the need for levodopa therapy in early Parkinson disease?
  17. Q17. Which pharmacological goal is the main aim of Parkinson disease drug therapy?
  18. Q18. Which symptom is part of the classic triad of Parkinson disease?
  19. Q19. Which drug mechanism increases dopamine levels by inhibiting its breakdown in the brain?
  20. Q20. Which outcome best describes the purpose of pharmacological therapy in Parkinson disease?